COPYRIGHT © DIGITAL JOURNAL INC. Sitemaps: XML / News. Digital Journal is not responsible for the content of external sites. Read more about our external linking
NEW YORK : Oral macromolecular formulations refer to the delivery of large molecule drugs through the oral route. Large molecule drugs, such as peptides, proteins, and nucleic acids, have gained attention in the pharmaceutical industry due to their potential therapeutic benefits. However, their delivery through the oral route is challenging due to their low bioavailability and susceptibility to degradation in the gastrointestinal tract. Oral macromolecular formulations have emerged as a solution to overcome these challenges and improve the therapeutic efficacy of large molecule drugs.
The global oral macromolecular formulation market has been growing rapidly in recent years, driven by the increasing demand for large molecule drugs, the need for alternative drug delivery systems, and the growing focus on personalized medicine. This report provides an overview of the market, including its size, trends, drivers, challenges, and opportunities.
Market Overview:
The global revenue from the oral macromolecule formulation market stands at US$ 17.2 Mn in 2022, with the global market expected to grow at a CAGR of 5.0% to reach a valuation of approximately US$ 29.5 Mn by the end of 2033.
As assessed by Persistence Market Research, diabetes indication is set to hold a market share of around 45.7% in 2023. Overall, oral macromolecule formulation market sales account for approximately 1.6% revenue share in the global oral proteins & peptides market, which was valued at around US$ 1.1 Bn in 2022. The global market recorded a historic CAGR of 4.2% in the last 6 years from 2016 to 2022.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32388
Company Profiles:
Drivers and Restraints:
Drivers: The increasing demand for large molecule drugs, the need for alternative drug delivery systems, and the growing focus on personalized medicine are the primary drivers for the oral macromolecular formulation market. Furthermore, the advantages of oral macromolecular formulations, such as improved bioavailability and reduced dosing frequency, are also driving the growth of the market.
Restraints: One of the major challenges faced by the oral macromolecular formulation market is the high cost of development and manufacturing. Large molecule drugs require advanced technologies and specialized equipment, which can increase the cost of production. Additionally, the regulatory approval process for oral macromolecular formulations can be lengthy and expensive, which can also hinder the growth of the market. Moreover, the lack of awareness and education among healthcare professionals and patients regarding the benefits of oral macromolecular formulations is another significant restraint.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32388
Key Segments Covered in Oral Macromolecule Formulation Industry Research
Indication:
End User:
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32388
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com